{"transactions":[{"id":803730,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":16816,"kind":"person","name":"Howton David T","position":1,"cik":"0001529297","reported_name":"Howton David T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2026-04-21T20:05:09.000Z","date":"2026-01-29","kind":"grant","planned":true,"acquired":true,"shares":79341,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock (the \"RSUs\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Performance stock units (\"PSUs\") were granted on June 11, 2024, and provide for the vesting of 25% of the target number of underlying RSUs granted upon the achievement of each of four independent performance milestones predetermined by the Board (\"Performance Milestones\"). The Performance Milestones are tied to the achievement of certain business objectives, as certified by the Board on specified evaluation dates, and are non-market and non-financial in nature. The performance criteria specified for the second Performance Milestone was determined by the Board to be met on January 29, 2026, and the shares related to such Performance Milestone will vest subject to the grantee's continued service with the Company on the Evaluation Date, which is anticipated to occur in the first quarter of 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Performance stock units (\"PSUs\") were granted on June 11, 2024, and provide for the vesting of 25% of the target number of underlying RSUs granted upon the achievement of each of four independent performance milestones predetermined by the Board (\"Performance Milestones\"). The Performance Milestones are tied to the achievement of certain business objectives, as certified by the Board on specified evaluation dates, and are non-market and non-financial in nature. The performance criteria specified for the second Performance Milestone was determined by the Board to be met on January 29, 2026, and the shares related to such Performance Milestone will vest subject to the grantee's continued service with the Company on the Evaluation Date, which is anticipated to occur in the first quarter of 2027."}],"balance_after":79341,"derivative":{"underlying":"Common Stock","underlying_shares":79341},"source":{"system":"sec-edgar","filing":"0001193125-26-166736","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000119312526166736/ownership.xml","form_type":"4"}},{"id":896920,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":16816,"kind":"person","name":"Howton David T","position":1,"cik":"0001529297","reported_name":"Howton David T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2026-02-19T02:31:11.000Z","date":"2026-02-13","kind":"exercise","planned":true,"acquired":false,"shares":14687,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock (the \"RSUs\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs were granted on February 13, 2024 (the \"Grant Date\") and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSUs were granted on February 13, 2024 (the \"Grant Date\") and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary."}],"balance_after":29376,"derivative":{"underlying":"Common Stock","underlying_shares":14687},"source":{"system":"sec-edgar","filing":"0001193125-26-057863","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000119312526057863/ownership.xml","form_type":"4"}},{"id":896919,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":16816,"kind":"person","name":"Howton David T","position":1,"cik":"0001529297","reported_name":"Howton David T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-02-19T02:31:11.000Z","date":"2026-02-18","kind":"sale","planned":true,"acquired":false,"shares":7469,"price":5.8233,"value":43494.2277,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This sale was made to cover withholding taxes following the vesting of the previously granted RSUs pursuant to a durable automatic sales instruction letter adopted by Mr. Howton on August 16, 2024 effecting the sell-to-cover election. The sale does not represent a discretionary trade by Mr. Howton."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.23 to $6.14, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (4) to this Form."}],"balance_after":105077,"source":{"system":"sec-edgar","filing":"0001193125-26-057863","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000119312526057863/ownership.xml","form_type":"4"}},{"id":896918,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":16816,"kind":"person","name":"Howton David T","position":1,"cik":"0001529297","reported_name":"Howton David T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-02-19T02:31:11.000Z","date":"2026-02-13","kind":"exercise","planned":true,"acquired":true,"shares":14687,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock (the \"RSUs\")."}],"balance_after":112546,"source":{"system":"sec-edgar","filing":"0001193125-26-057863","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000119312526057863/ownership.xml","form_type":"4"}},{"id":916054,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":16816,"kind":"person","name":"Howton David T","position":1,"cik":"0001529297","reported_name":"Howton David T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-02-06T23:05:06.000Z","date":"2026-02-04","kind":"sale","planned":true,"acquired":false,"shares":18894,"price":6.4419,"value":121713.2586,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This sale was made to cover withholding taxes following the vesting of previously granted restricted stock units pursuant to a durable automatic sale instruction letter adopted by Mr. Howton on August 16, 2024 effecting the sell-to-cover election. The sale does not represent a discretionary trade by Mr. Howton."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.28 to $6.60, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (4) to this Form."}],"balance_after":97859,"source":{"system":"sec-edgar","filing":"0001193125-26-041523","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000119312526041523/ownership.xml","form_type":"4"}},{"id":925131,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":16816,"kind":"person","name":"Howton David T","position":1,"cik":"0001529297","reported_name":"Howton David T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2026-02-03T01:12:02.000Z","date":"2026-01-31","kind":"exercise","planned":true,"acquired":false,"shares":42275,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSUs\") converts to common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"On January 31, 2025 (the \"2025 Grant Date\"), the reporting person was granted 169,100 RSUs, with 25% of the original number of shares vesting on each anniversary of the 2025 Grant Date until the fourth such anniversary."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"On January 31, 2025 (the \"2025 Grant Date\"), the reporting person was granted 169,100 RSUs, with 25% of the original number of shares vesting on each anniversary of the 2025 Grant Date until the fourth such anniversary."}],"balance_after":126825,"derivative":{"underlying":"Common Stock","underlying_shares":42275},"source":{"system":"sec-edgar","filing":"0001193125-26-034080","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000119312526034080/ownership.xml","form_type":"4"}},{"id":925130,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":16816,"kind":"person","name":"Howton David T","position":1,"cik":"0001529297","reported_name":"Howton David T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2026-02-03T01:12:02.000Z","date":"2026-01-29","kind":"grant","planned":true,"acquired":true,"shares":105100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSUs\") converts to common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The RSUs were granted on the 2026 Grant Date and vest over four years, with 25% of the original number of shares vesting on each anniversary of the 2026 Grant Date until the fourth such anniversary."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"The RSUs were granted on the 2026 Grant Date and vest over four years, with 25% of the original number of shares vesting on each anniversary of the 2026 Grant Date until the fourth such anniversary."}],"balance_after":105100,"derivative":{"underlying":"Common Stock","underlying_shares":105100},"source":{"system":"sec-edgar","filing":"0001193125-26-034080","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000119312526034080/ownership.xml","form_type":"4"}},{"id":925129,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":16816,"kind":"person","name":"Howton David T","position":1,"cik":"0001529297","reported_name":"Howton David T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-02-03T01:12:02.000Z","date":"2026-01-29","kind":"grant","planned":true,"acquired":true,"shares":210200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This option was granted on the 2026 Grant Date and vests over four years, with 25% of the original number of shares vesting on the first anniversary of the 2026 Grant Date and 2.0833% of the original number of shares monthly thereafter until the fourth such anniversary."}],"balance_after":210200,"derivative":{"exercise_price":6.6,"expiration_date":"2036-01-29","underlying":"Common Stock","underlying_shares":210200},"source":{"system":"sec-edgar","filing":"0001193125-26-034080","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000119312526034080/ownership.xml","form_type":"4"}},{"id":925128,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":16816,"kind":"person","name":"Howton David T","position":1,"cik":"0001529297","reported_name":"Howton David T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Performance Stock Units","published_at":"2026-02-03T01:12:02.000Z","date":"2026-01-29","kind":"exercise","planned":true,"acquired":false,"shares":79341,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each performance stock unit (\"PSUs\") converts to common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The PSUs were granted on June 11, 2024 and provide for the vesting of 25% of the target number of underlying RSUs granted upon the achievement of each of four independent performance milestones predetermined by the Board (\"Performance Milestones\"), subject to the grantee's continued service with the Company (the \"Approval Conditions\"). The Performance Milestones are tied to the achievement of certain business objectives, as certified by the Board on specified evaluation dates, and are non-market and non-financial in nature. The performance criteria specified for the first Performance Milestone was determined to be met on January 29, 2026 (the \"2026 Grant Date\") resulting in the vesting of the PSUs as to 25% of the underlying shares."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The PSUs were granted on June 11, 2024 and provide for the vesting of 25% of the target number of underlying RSUs granted upon the achievement of each of four independent performance milestones predetermined by the Board (\"Performance Milestones\"), subject to the grantee's continued service with the Company (the \"Approval Conditions\"). The Performance Milestones are tied to the achievement of certain business objectives, as certified by the Board on specified evaluation dates, and are non-market and non-financial in nature. The performance criteria specified for the first Performance Milestone was determined to be met on January 29, 2026 (the \"2026 Grant Date\") resulting in the vesting of the PSUs as to 25% of the underlying shares."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":79341},"source":{"system":"sec-edgar","filing":"0001193125-26-034080","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000119312526034080/ownership.xml","form_type":"4"}},{"id":925127,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":16816,"kind":"person","name":"Howton David T","position":1,"cik":"0001529297","reported_name":"Howton David T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-02-03T01:12:02.000Z","date":"2026-02-02","kind":"sale","planned":true,"acquired":false,"shares":37771,"price":6.4369,"value":243128.1499,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"This sale was made to cover withholding taxes following the vesting of previously granted PSUs pursuant to a durable automatic sale instruction letter adopted by Mr. Howton on August 16, 2024 effecting the sell-to-cover election. The sale does not represent a discretionary trade by Mr. Howton."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.295 to $6.580, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (4) to this Form."}],"balance_after":116753,"source":{"system":"sec-edgar","filing":"0001193125-26-034080","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000119312526034080/ownership.xml","form_type":"4"}},{"id":925126,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":16816,"kind":"person","name":"Howton David T","position":1,"cik":"0001529297","reported_name":"Howton David T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-02-03T01:12:02.000Z","date":"2026-01-31","kind":"exercise","planned":true,"acquired":true,"shares":42275,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit (\"RSUs\") converts to common stock on a one-for-one basis."}],"balance_after":154254,"source":{"system":"sec-edgar","filing":"0001193125-26-034080","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000119312526034080/ownership.xml","form_type":"4"}},{"id":925125,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":16816,"kind":"person","name":"Howton David T","position":1,"cik":"0001529297","reported_name":"Howton David T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-02-03T01:12:02.000Z","date":"2026-01-29","kind":"exercise","planned":true,"acquired":true,"shares":79341,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each performance stock unit (\"PSUs\") converts to common stock on a one-for-one basis."}],"balance_after":112249,"source":{"system":"sec-edgar","filing":"0001193125-26-034080","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000119312526034080/ownership.xml","form_type":"4"}},{"id":980331,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":16816,"kind":"person","name":"Howton David T","position":1,"cik":"0001529297","reported_name":"Howton David T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2025-12-04T21:22:10.000Z","date":"2025-12-02","kind":"exercise","planned":true,"acquired":false,"shares":13051,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock (the \"RSUs\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs were granted on December 2, 2022 (the \"Grant Date\") and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs were granted on December 2, 2022 (the \"Grant Date\") and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary."}],"balance_after":13052,"derivative":{"underlying":"Common Stock","underlying_shares":13051},"source":{"system":"sec-edgar","filing":"0001193125-25-308118","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000119312525308118/ownership.xml","form_type":"4"}},{"id":980330,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":16816,"kind":"person","name":"Howton David T","position":1,"cik":"0001529297","reported_name":"Howton David T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2025-12-04T21:22:10.000Z","date":"2025-12-03","kind":"sale","planned":true,"acquired":false,"shares":4932,"price":5.11,"value":25202.52,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This sale was made to cover withholding taxes following the vesting of the previously granted RSUs pursuant to a durable automatic sales instruction letter adopted by Mr. Howton on August 16, 2024 effecting the sell-to-cover election. The sale does not represent a discretionary trade by Mr. Howton."}],"balance_after":32908,"source":{"system":"sec-edgar","filing":"0001193125-25-308118","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000119312525308118/ownership.xml","form_type":"4"}},{"id":980329,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":16816,"kind":"person","name":"Howton David T","position":1,"cik":"0001529297","reported_name":"Howton David T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2025-12-04T21:22:10.000Z","date":"2025-12-02","kind":"exercise","planned":true,"acquired":true,"shares":13051,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock (the \"RSUs\")."}],"balance_after":37840,"source":{"system":"sec-edgar","filing":"0001193125-25-308118","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000119312525308118/ownership.xml","form_type":"4"}},{"id":1063982,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":16816,"kind":"person","name":"Howton David T","position":1,"cik":"0001529297","reported_name":"Howton David T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2025-08-18T20:16:16.000Z","date":"2025-08-14","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock (the \"RSUs\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The RSUs (as defined in footnote 2) together with this option were granted on August 14, 2025 (the \"Grant Date\") and vest over four years, with 50% of the original number of shares vesting on the second anniversary of the Grant Date and 25% of the original number of shares annually thereafter until the fourth such anniversary."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The RSUs (as defined in footnote 2) together with this option were granted on August 14, 2025 (the \"Grant Date\") and vest over four years, with 50% of the original number of shares vesting on the second anniversary of the Grant Date and 25% of the original number of shares annually thereafter until the fourth such anniversary."}],"balance_after":75000,"derivative":{"underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0000950170-25-109736","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000095017025109736/ownership.xml","form_type":"4"}},{"id":1063981,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":16816,"kind":"person","name":"Howton David T","position":1,"cik":"0001529297","reported_name":"Howton David T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-08-18T20:16:16.000Z","date":"2025-08-14","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The RSUs (as defined in footnote 2) together with this option were granted on August 14, 2025 (the \"Grant Date\") and vest over four years, with 50% of the original number of shares vesting on the second anniversary of the Grant Date and 25% of the original number of shares annually thereafter until the fourth such anniversary."}],"balance_after":150000,"derivative":{"exercise_price":6.17,"expiration_date":"2035-08-14","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0000950170-25-109736","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000095017025109736/ownership.xml","form_type":"4"}},{"id":1263833,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":16816,"kind":"person","name":"Howton David T","position":1,"cik":"0001529297","reported_name":"Howton David T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2025-02-18T21:05:05.000Z","date":"2025-02-13","kind":"exercise","planned":true,"acquired":false,"shares":14687,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock (the \"RSUs\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs were granted on February 13, 2024 (the \"Grant Date\") and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs were granted on February 13, 2024 (the \"Grant Date\") and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary."}],"balance_after":44063,"derivative":{"underlying":"Common Stock","underlying_shares":14687},"source":{"system":"sec-edgar","filing":"0000950170-25-022196","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000095017025022196/ownership.xml","form_type":"4"}},{"id":1263832,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":16816,"kind":"person","name":"Howton David T","position":1,"cik":"0001529297","reported_name":"Howton David T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2025-02-18T21:05:05.000Z","date":"2025-02-14","kind":"sale","planned":true,"acquired":false,"shares":5561,"price":3.96,"value":22021.56,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This sale was made to cover withholding taxes following the vesting of the previously granted RSUs pursuant to a durable automatic sales instruction letter adopted by Mr. Howton on August 16, 2024 effecting the sell-to-cover election. The sale does not represent a discretionary trade by Mr. Howton."}],"balance_after":24789,"source":{"system":"sec-edgar","filing":"0000950170-25-022196","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000095017025022196/ownership.xml","form_type":"4"}},{"id":1263831,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":16816,"kind":"person","name":"Howton David T","position":1,"cik":"0001529297","reported_name":"Howton David T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2025-02-18T21:05:05.000Z","date":"2025-02-13","kind":"exercise","planned":true,"acquired":true,"shares":14687,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock (the \"RSUs\")."}],"balance_after":30350,"source":{"system":"sec-edgar","filing":"0000950170-25-022196","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000095017025022196/ownership.xml","form_type":"4"}},{"id":1274056,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":16816,"kind":"person","name":"Howton David T","position":1,"cik":"0001529297","reported_name":"Howton David T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2025-02-11T21:38:31.000Z","date":"2025-01-31","kind":"grant","planned":false,"acquired":true,"shares":169100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock (the \"RSUs\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs were granted on the January 31, 2025 (the \"Grant Date\") and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs were granted on the January 31, 2025 (the \"Grant Date\") and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary."}],"balance_after":169100,"derivative":{"underlying":"Common Stock","underlying_shares":169100},"source":{"system":"sec-edgar","filing":"0000950170-25-017962","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000095017025017962/ownership.xml","form_type":"4"}},{"id":1342978,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":16816,"kind":"person","name":"Howton David T","position":1,"cik":"0001529297","reported_name":"Howton David T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2024-12-04T22:04:13.000Z","date":"2024-12-02","kind":"exercise","planned":false,"acquired":false,"shares":13051,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock (the \"RSUs\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs were granted on December 2, 2022 (the \"Grant Date\") and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs were granted on December 2, 2022 (the \"Grant Date\") and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary."}],"balance_after":26103,"derivative":{"underlying":"Common Stock","underlying_shares":13051},"source":{"system":"sec-edgar","filing":"0000950170-24-133340","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000095017024133340/ownership.xml","form_type":"4"}},{"id":1342977,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":16816,"kind":"person","name":"Howton David T","position":1,"cik":"0001529297","reported_name":"Howton David T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2024-12-04T22:04:13.000Z","date":"2024-12-03","kind":"sale","planned":false,"acquired":false,"shares":5072,"price":5.5986,"value":28396.0992,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This sale was made to cover withholding taxes following the vesting of the previously granted RSUs. The sale does not represent a discretionary trade made by Mr. Howton."}],"balance_after":15663,"source":{"system":"sec-edgar","filing":"0000950170-24-133340","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000095017024133340/ownership.xml","form_type":"4"}},{"id":1342976,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":16816,"kind":"person","name":"Howton David T","position":1,"cik":"0001529297","reported_name":"Howton David T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2024-12-04T22:04:13.000Z","date":"2024-12-02","kind":"exercise","planned":false,"acquired":true,"shares":13051,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock (the \"RSUs\")."}],"balance_after":20735,"source":{"system":"sec-edgar","filing":"0000950170-24-133340","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000095017024133340/ownership.xml","form_type":"4"}},{"id":1638320,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":16816,"kind":"person","name":"Howton David T","position":1,"cik":"0001529297","reported_name":"Howton David T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2024-02-16T16:28:40.000Z","date":"2024-02-13","kind":"grant","planned":false,"acquired":true,"shares":58750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock (the \"RSUs\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs were granted on the Grant Date and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs were granted on the Grant Date and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary."}],"balance_after":58750,"derivative":{"underlying":"Common Stock","underlying_shares":58750},"source":{"system":"sec-edgar","filing":"0000950170-24-016193","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000095017024016193/ownership.xml","form_type":"4"}},{"id":1638319,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":16816,"kind":"person","name":"Howton David T","position":1,"cik":"0001529297","reported_name":"Howton David T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2024-02-16T16:28:40.000Z","date":"2024-02-13","kind":"grant","planned":false,"acquired":true,"shares":117500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on February 13, 2024 (the \"Grant Date\") and vests over four years, with 25% of the original number of shares vesting on the first anniversary of the Grant Date and 2.0833% of the original number of shares monthly thereafter until the fourth such anniversary."}],"balance_after":117500,"derivative":{"exercise_price":7.85,"expiration_date":"2034-02-13","underlying":"Common Stock","underlying_shares":117500},"source":{"system":"sec-edgar","filing":"0000950170-24-016193","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000095017024016193/ownership.xml","form_type":"4"}},{"id":1721781,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":16816,"kind":"person","name":"Howton David T","position":1,"cik":"0001529297","reported_name":"Howton David T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2023-12-05T19:32:52.000Z","date":"2023-12-02","kind":"exercise","planned":false,"acquired":false,"shares":13051,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock (the \"RSUs\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs were granted on December 2, 2022 (the \"Grant Date\") and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs were granted on December 2, 2022 (the \"Grant Date\") and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary."}],"balance_after":39154,"derivative":{"underlying":"Common Stock","underlying_shares":13051},"source":{"system":"sec-edgar","filing":"0000950170-23-068067","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000095017023068067/ownership.xml","form_type":"4"}},{"id":1721780,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":16816,"kind":"person","name":"Howton David T","position":1,"cik":"0001529297","reported_name":"Howton David T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2023-12-05T19:32:52.000Z","date":"2023-12-04","kind":"sale","planned":false,"acquired":false,"shares":5367,"price":2.78,"value":14920.26,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This sale was made to cover withholding taxes following the vesting of the previously granted RSUs. The shares were sold pursuant to a written instruction under Rule 10b5-1(c)(1)."}],"balance_after":7684,"source":{"system":"sec-edgar","filing":"0000950170-23-068067","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000095017023068067/ownership.xml","form_type":"4"}},{"id":1721779,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":16816,"kind":"person","name":"Howton David T","position":1,"cik":"0001529297","reported_name":"Howton David T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2023-12-05T19:32:52.000Z","date":"2023-12-02","kind":"exercise","planned":false,"acquired":true,"shares":13051,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock (the \"RSUs\")."}],"balance_after":13051,"source":{"system":"sec-edgar","filing":"0000950170-23-068067","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000095017023068067/ownership.xml","form_type":"4"}},{"id":2096196,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":16816,"kind":"person","name":"Howton David T","position":1,"cik":"0001529297","reported_name":"Howton David T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2022-12-05T22:50:46.000Z","date":"2022-12-02","kind":"grant","acquired":true,"shares":52205,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock (the \"RSUs\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs were granted on the Grant Date and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs were granted on the Grant Date and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary."}],"balance_after":52205,"derivative":{"underlying":"Common Stock","underlying_shares":52205},"source":{"system":"sec-edgar","filing":"0000899243-22-037686","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000089924322037686/doc4.xml","form_type":"4"}},{"id":2096195,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":16816,"kind":"person","name":"Howton David T","position":1,"cik":"0001529297","reported_name":"Howton David T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-12-05T22:50:46.000Z","date":"2022-12-02","kind":"grant","acquired":true,"shares":104410,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on December 2, 2022 (the \"Grant Date\") and vests over four years, with 25% of the original number of shares vesting on the first anniversary of the Grant Date and 2.0833% of the original number of shares on the first day of each calendar month thereafter until the fourth such anniversary."}],"balance_after":104410,"derivative":{"exercise_price":6.77,"expiration_date":"2032-12-02","underlying":"Common Stock","underlying_shares":104410},"source":{"system":"sec-edgar","filing":"0000899243-22-037686","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000089924322037686/doc4.xml","form_type":"4"}},{"id":3103556,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":16816,"kind":"person","name":"Howton David T","position":1,"cik":"0001529297","reported_name":"Howton David T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Stock option (right to buy)","published_at":"2020-06-23T01:17:56.000Z","date":"2020-06-22","kind":"exercise","acquired":false,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person. Accordingly, the reporting person had no discretion with regards to the timing of the transaction."}],"balance_after":7708,"derivative":{"exercise_price":29.03,"exercise_date":"2015-02-28","expiration_date":"2024-02-28","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001209191-20-038339","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919120038339/doc4.xml","form_type":"4"}},{"id":3103555,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":16816,"kind":"person","name":"Howton David T","position":1,"cik":"0001529297","reported_name":"Howton David T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Stock option (right to buy)","published_at":"2020-06-23T01:17:56.000Z","date":"2020-06-22","kind":"exercise","acquired":false,"shares":56984,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person. Accordingly, the reporting person had no discretion with regards to the timing of the transaction."}],"balance_after":0,"derivative":{"exercise_price":23.85,"exercise_date":"2013-11-05","expiration_date":"2022-11-05","underlying":"Common Stock","underlying_shares":56984},"source":{"system":"sec-edgar","filing":"0001209191-20-038339","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919120038339/doc4.xml","form_type":"4"}},{"id":3103554,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":16816,"kind":"person","name":"Howton David T","position":1,"cik":"0001529297","reported_name":"Howton David T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Stock option (right to buy)","published_at":"2020-06-23T01:17:56.000Z","date":"2020-06-22","kind":"exercise","acquired":false,"shares":1858,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person. Accordingly, the reporting person had no discretion with regards to the timing of the transaction."}],"balance_after":0,"derivative":{"exercise_price":13.71,"exercise_date":"2017-02-28","expiration_date":"2026-02-28","underlying":"Common Stock","underlying_shares":1858},"source":{"system":"sec-edgar","filing":"0001209191-20-038339","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919120038339/doc4.xml","form_type":"4"}},{"id":3103553,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":16816,"kind":"person","name":"Howton David T","position":1,"cik":"0001529297","reported_name":"Howton David T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Stock option (right to buy)","published_at":"2020-06-23T01:17:56.000Z","date":"2020-06-22","kind":"exercise","acquired":false,"shares":1280,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person. Accordingly, the reporting person had no discretion with regards to the timing of the transaction."}],"balance_after":0,"derivative":{"exercise_price":13.71,"exercise_date":"2017-02-28","expiration_date":"2026-02-28","underlying":"Common Stock","underlying_shares":1280},"source":{"system":"sec-edgar","filing":"0001209191-20-038339","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919120038339/doc4.xml","form_type":"4"}},{"id":3103552,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":16816,"kind":"person","name":"Howton David T","position":1,"cik":"0001529297","reported_name":"Howton David T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2020-06-23T01:17:56.000Z","date":"2020-06-22","kind":"sale","acquired":false,"shares":55270,"price":171.5,"value":9478805.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person. Accordingly, the reporting person had no discretion with regards to the timing of the transaction."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The shares were sold in transactions at prices ranging from $171.09 to $172.0899, inclusive. The reporting person undertakes to provide to Sarepta Therapeutics, Inc., any security holder of Sarepta Therapeutics, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein."}],"balance_after":31871,"source":{"system":"sec-edgar","filing":"0001209191-20-038339","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919120038339/doc4.xml","form_type":"4"}},{"id":3103551,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":16816,"kind":"person","name":"Howton David T","position":1,"cik":"0001529297","reported_name":"Howton David T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2020-06-23T01:17:56.000Z","date":"2020-06-22","kind":"sale","acquired":false,"shares":35757,"price":170.59,"value":6099786.63,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person. Accordingly, the reporting person had no discretion with regards to the timing of the transaction."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The shares were sold in transactions at prices ranging from $170.09 to $171.0899, inclusive. The reporting person undertakes to provide to Sarepta Therapeutics, Inc., any security holder of Sarepta Therapeutics, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein."}],"balance_after":87141,"source":{"system":"sec-edgar","filing":"0001209191-20-038339","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919120038339/doc4.xml","form_type":"4"}},{"id":3103550,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":16816,"kind":"person","name":"Howton David T","position":1,"cik":"0001529297","reported_name":"Howton David T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2020-06-23T01:17:56.000Z","date":"2020-06-22","kind":"sale","acquired":false,"shares":8086,"price":169.56,"value":1371062.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person. Accordingly, the reporting person had no discretion with regards to the timing of the transaction."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The shares were sold in transactions at prices ranging from $169.09 to $170.0899, inclusive. The reporting person undertakes to provide to Sarepta Therapeutics, Inc., any security holder of Sarepta Therapeutics, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein."}],"balance_after":122898,"source":{"system":"sec-edgar","filing":"0001209191-20-038339","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919120038339/doc4.xml","form_type":"4"}},{"id":3103549,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":16816,"kind":"person","name":"Howton David T","position":1,"cik":"0001529297","reported_name":"Howton David T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2020-06-23T01:17:56.000Z","date":"2020-06-22","kind":"sale","acquired":false,"shares":6009,"price":168.61,"value":1013177.49,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person. Accordingly, the reporting person had no discretion with regards to the timing of the transaction."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in transactions at prices ranging from $168.04 to $169.0399, inclusive. The reporting person undertakes to provide to Sarepta Therapeutics, Inc., any security holder of Sarepta Therapeutics, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein."}],"balance_after":130984,"source":{"system":"sec-edgar","filing":"0001209191-20-038339","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919120038339/doc4.xml","form_type":"4"}},{"id":3103548,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":16816,"kind":"person","name":"Howton David T","position":1,"cik":"0001529297","reported_name":"Howton David T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2020-06-23T01:17:56.000Z","date":"2020-06-22","kind":"exercise","acquired":true,"shares":45000,"price":29.03,"value":1306350.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person. Accordingly, the reporting person had no discretion with regards to the timing of the transaction."}],"balance_after":136993,"source":{"system":"sec-edgar","filing":"0001209191-20-038339","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919120038339/doc4.xml","form_type":"4"}},{"id":3103547,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":16816,"kind":"person","name":"Howton David T","position":1,"cik":"0001529297","reported_name":"Howton David T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2020-06-23T01:17:56.000Z","date":"2020-06-22","kind":"exercise","acquired":true,"shares":56984,"price":23.85,"value":1359068.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person. Accordingly, the reporting person had no discretion with regards to the timing of the transaction."}],"balance_after":91993,"source":{"system":"sec-edgar","filing":"0001209191-20-038339","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919120038339/doc4.xml","form_type":"4"}},{"id":3103546,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":16816,"kind":"person","name":"Howton David T","position":1,"cik":"0001529297","reported_name":"Howton David T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2020-06-23T01:17:56.000Z","date":"2020-06-22","kind":"exercise","acquired":true,"shares":1858,"price":13.71,"value":25473.18,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person. Accordingly, the reporting person had no discretion with regards to the timing of the transaction."}],"balance_after":35009,"source":{"system":"sec-edgar","filing":"0001209191-20-038339","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919120038339/doc4.xml","form_type":"4"}},{"id":3103545,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":16816,"kind":"person","name":"Howton David T","position":1,"cik":"0001529297","reported_name":"Howton David T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2020-06-23T01:17:56.000Z","date":"2020-06-22","kind":"exercise","acquired":true,"shares":1280,"price":13.71,"value":17548.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person. Accordingly, the reporting person had no discretion with regards to the timing of the transaction."}],"balance_after":33151,"source":{"system":"sec-edgar","filing":"0001209191-20-038339","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919120038339/doc4.xml","form_type":"4"}},{"id":3242219,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":16816,"kind":"person","name":"Howton David T","position":1,"cik":"0001529297","reported_name":"Howton David T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Stock option (right to buy)","published_at":"2020-02-29T01:01:07.000Z","date":"2020-02-28","kind":"grant","acquired":true,"shares":37500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the option granted vests and is exercisable on the first anniversary of the date of grant and 1/48th of the total granted option will vest and\nbecome exercisable on each monthly anniversary thereafter, such that the option will be fully vested and exercisable on the fourth anniversary of\nthe date of grant."}],"balance_after":37500,"derivative":{"exercise_price":114.47,"expiration_date":"2030-02-28","underlying":"Common Stock","underlying_shares":37500},"source":{"system":"sec-edgar","filing":"0001209191-20-014224","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919120014224/doc4.xml","form_type":"4"}},{"id":3242218,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":16816,"kind":"person","name":"Howton David T","position":1,"cik":"0001529297","reported_name":"Howton David T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2020-02-29T01:01:07.000Z","date":"2020-02-28","kind":"grant","acquired":true,"shares":6700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock. 25% of\nthe shares of common stock underlying each RSU will vest and become exercisable on the first anniversary of the grant date, and additional 25%\nwill vest and become exercisable on each anniversary of the Grant Date thereafter, such that the RSUs will be fully vested and exercisable on the\nfourth anniversary of the grant date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock. 25% of\nthe shares of common stock underlying each RSU will vest and become exercisable on the first anniversary of the grant date, and additional 25%\nwill vest and become exercisable on each anniversary of the Grant Date thereafter, such that the RSUs will be fully vested and exercisable on the\nfourth anniversary of the grant date."}],"balance_after":31871,"source":{"system":"sec-edgar","filing":"0001209191-20-014224","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919120014224/doc4.xml","form_type":"4"}},{"id":3339784,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":16816,"kind":"person","name":"Howton David T","position":1,"cik":"0001529297","reported_name":"Howton David T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Stock option (right to buy)","published_at":"2019-12-18T01:01:20.000Z","date":"2019-12-13","kind":"exercise","acquired":false,"shares":59421,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person. Accordingly, the reporting person had no discretion with regards to the timing of the transaction."}],"balance_after":56984,"derivative":{"exercise_price":23.85,"exercise_date":"2013-11-05","expiration_date":"2022-11-05","underlying":"Common Stock","underlying_shares":59421},"source":{"system":"sec-edgar","filing":"0001209191-19-061049","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919119061049/doc4.xml","form_type":"4"}},{"id":3339783,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":16816,"kind":"person","name":"Howton David T","position":1,"cik":"0001529297","reported_name":"Howton David T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Stock option (right to buy)","published_at":"2019-12-18T01:01:20.000Z","date":"2019-12-13","kind":"exercise","acquired":false,"shares":18579,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person. Accordingly, the reporting person had no discretion with regards to the timing of the transaction."}],"balance_after":0,"derivative":{"exercise_price":13.9,"exercise_date":"2016-02-27","expiration_date":"2025-02-27","underlying":"Common Stock","underlying_shares":18579},"source":{"system":"sec-edgar","filing":"0001209191-19-061049","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919119061049/doc4.xml","form_type":"4"}},{"id":3339782,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":16816,"kind":"person","name":"Howton David T","position":1,"cik":"0001529297","reported_name":"Howton David T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2019-12-18T01:01:20.000Z","date":"2019-12-13","kind":"sale","acquired":false,"shares":78000,"price":125.5,"value":9789000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person. Accordingly, the reporting person had no discretion with regards to the timing of the transaction."}],"balance_after":25171,"source":{"system":"sec-edgar","filing":"0001209191-19-061049","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919119061049/doc4.xml","form_type":"4"}},{"id":3339781,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":16816,"kind":"person","name":"Howton David T","position":1,"cik":"0001529297","reported_name":"Howton David T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2019-12-18T01:01:20.000Z","date":"2019-12-13","kind":"exercise","acquired":true,"shares":59421,"price":23.85,"value":1417190.85,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person. Accordingly, the reporting person had no discretion with regards to the timing of the transaction."}],"balance_after":103171,"source":{"system":"sec-edgar","filing":"0001209191-19-061049","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919119061049/doc4.xml","form_type":"4"}},{"id":3339780,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":16816,"kind":"person","name":"Howton David T","position":1,"cik":"0001529297","reported_name":"Howton David T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2019-12-18T01:01:20.000Z","date":"2019-12-13","kind":"exercise","acquired":true,"shares":18579,"price":13.9,"value":258248.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person. Accordingly, the reporting person had no discretion with regards to the timing of the transaction."}],"balance_after":43750,"source":{"system":"sec-edgar","filing":"0001209191-19-061049","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919119061049/doc4.xml","form_type":"4"}},{"id":3359341,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":16816,"kind":"person","name":"Howton David T","position":1,"cik":"0001529297","reported_name":"Howton David T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Stock option (right to buy)","published_at":"2019-11-27T01:01:00.000Z","date":"2019-11-22","kind":"exercise","acquired":false,"shares":7900,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":5118,"derivative":{"exercise_price":23.85,"exercise_date":"2013-11-05","expiration_date":"2022-11-05","underlying":"Common Stock","underlying_shares":7900},"source":{"system":"sec-edgar","filing":"0001209191-19-058217","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919119058217/doc4.xml","form_type":"4"}},{"id":3359340,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":16816,"kind":"person","name":"Howton David T","position":1,"cik":"0001529297","reported_name":"Howton David T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Stock option (right to buy)","published_at":"2019-11-27T01:01:00.000Z","date":"2019-11-22","kind":"exercise","acquired":false,"shares":5590,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":13.9,"exercise_date":"2016-02-27","expiration_date":"2025-02-27","underlying":"Common Stock","underlying_shares":5590},"source":{"system":"sec-edgar","filing":"0001209191-19-058217","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919119058217/doc4.xml","form_type":"4"}},{"id":3359339,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":16816,"kind":"person","name":"Howton David T","position":1,"cik":"0001529297","reported_name":"Howton David T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Stock option (right to buy)","published_at":"2019-11-27T01:01:00.000Z","date":"2019-11-22","kind":"exercise","acquired":false,"shares":52,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":18,"derivative":{"exercise_price":13.71,"exercise_date":"2016-09-19","expiration_date":"2026-02-28","underlying":"Common Stock","underlying_shares":52},"source":{"system":"sec-edgar","filing":"0001209191-19-058217","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919119058217/doc4.xml","form_type":"4"}},{"id":3359338,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":16816,"kind":"person","name":"Howton David T","position":1,"cik":"0001529297","reported_name":"Howton David T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Stock option (right to buy)","published_at":"2019-11-27T01:01:00.000Z","date":"2019-11-22","kind":"exercise","acquired":false,"shares":2440,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":2470,"derivative":{"exercise_price":13.71,"exercise_date":"2017-02-28","expiration_date":"2026-02-28","underlying":"Common Stock","underlying_shares":2440},"source":{"system":"sec-edgar","filing":"0001209191-19-058217","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919119058217/doc4.xml","form_type":"4"}},{"id":3359337,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":16816,"kind":"person","name":"Howton David T","position":1,"cik":"0001529297","reported_name":"Howton David T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Stock option (right to buy)","published_at":"2019-11-27T01:01:00.000Z","date":"2019-11-22","kind":"exercise","acquired":false,"shares":8580,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person. Accordingly, the reporting person had no discretion with regards to the timing of the transaction."}],"balance_after":18579,"derivative":{"exercise_price":13.9,"exercise_date":"2016-02-27","expiration_date":"2025-02-27","underlying":"Common Stock","underlying_shares":8580},"source":{"system":"sec-edgar","filing":"0001209191-19-058217","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919119058217/doc4.xml","form_type":"4"}},{"id":3359336,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":16816,"kind":"person","name":"Howton David T","position":1,"cik":"0001529297","reported_name":"Howton David T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Stock option (right to buy)","published_at":"2019-11-27T01:01:00.000Z","date":"2019-11-22","kind":"exercise","acquired":false,"shares":4025,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person. Accordingly, the reporting person had no discretion with regards to the timing of the transaction."}],"balance_after":1858,"derivative":{"exercise_price":13.71,"exercise_date":"2016-09-19","expiration_date":"2026-02-28","underlying":"Common Stock","underlying_shares":4025},"source":{"system":"sec-edgar","filing":"0001209191-19-058217","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919119058217/doc4.xml","form_type":"4"}},{"id":3359335,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":16816,"kind":"person","name":"Howton David T","position":1,"cik":"0001529297","reported_name":"Howton David T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Stock option (right to buy)","published_at":"2019-11-27T01:01:00.000Z","date":"2019-11-22","kind":"exercise","acquired":false,"shares":5685,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person. Accordingly, the reporting person had no discretion with regards to the timing of the transaction."}],"balance_after":1280,"derivative":{"exercise_price":13.71,"exercise_date":"2017-02-28","expiration_date":"2026-02-28","underlying":"Common Stock","underlying_shares":5685},"source":{"system":"sec-edgar","filing":"0001209191-19-058217","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919119058217/doc4.xml","form_type":"4"}},{"id":3359334,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":16816,"kind":"person","name":"Howton David T","position":1,"cik":"0001529297","reported_name":"Howton David T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2019-11-27T01:01:00.000Z","date":"2019-11-22","kind":"tax_withholding","acquired":false,"shares":2804,"price":107.02,"value":300084.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares of Common Stock owned by the reporting person that were delivered to the Company to pay the aggregate exercise price with respect to the option exercises reported in rows 4-7 in Table II of this Form 4 filing."}],"balance_after":25171,"source":{"system":"sec-edgar","filing":"0001209191-19-058217","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919119058217/doc4.xml","form_type":"4"}},{"id":3359333,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":16816,"kind":"person","name":"Howton David T","position":1,"cik":"0001529297","reported_name":"Howton David T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2019-11-27T01:01:00.000Z","date":"2019-11-22","kind":"exercise","acquired":true,"shares":7900,"price":23.85,"value":188415.0,"ownership":{"direct":true},"balance_after":27975,"source":{"system":"sec-edgar","filing":"0001209191-19-058217","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919119058217/doc4.xml","form_type":"4"}},{"id":3359332,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":16816,"kind":"person","name":"Howton David T","position":1,"cik":"0001529297","reported_name":"Howton David T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2019-11-27T01:01:00.000Z","date":"2019-11-22","kind":"exercise","acquired":true,"shares":5590,"price":13.9,"value":77701.0,"ownership":{"direct":true},"balance_after":20075,"source":{"system":"sec-edgar","filing":"0001209191-19-058217","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919119058217/doc4.xml","form_type":"4"}},{"id":3359331,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":16816,"kind":"person","name":"Howton David T","position":1,"cik":"0001529297","reported_name":"Howton David T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2019-11-27T01:01:00.000Z","date":"2019-11-22","kind":"exercise","acquired":true,"shares":52,"price":13.71,"value":712.92,"ownership":{"direct":true},"balance_after":14485,"source":{"system":"sec-edgar","filing":"0001209191-19-058217","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919119058217/doc4.xml","form_type":"4"}},{"id":3359330,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":16816,"kind":"person","name":"Howton David T","position":1,"cik":"0001529297","reported_name":"Howton David T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2019-11-27T01:01:00.000Z","date":"2019-11-22","kind":"exercise","acquired":true,"shares":2440,"price":13.71,"value":33452.4,"ownership":{"direct":true},"balance_after":14433,"source":{"system":"sec-edgar","filing":"0001209191-19-058217","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919119058217/doc4.xml","form_type":"4"}},{"id":3359329,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":16816,"kind":"person","name":"Howton David T","position":1,"cik":"0001529297","reported_name":"Howton David T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2019-11-27T01:01:00.000Z","date":"2019-11-22","kind":"sale","acquired":false,"shares":2957,"price":105,"value":310485.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person. Accordingly, the reporting person had no discretion with regards to the timing of the transaction."}],"balance_after":11993,"source":{"system":"sec-edgar","filing":"0001209191-19-058217","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919119058217/doc4.xml","form_type":"4"}},{"id":3359328,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":16816,"kind":"person","name":"Howton David T","position":1,"cik":"0001529297","reported_name":"Howton David T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2019-11-27T01:01:00.000Z","date":"2019-11-22","kind":"sale","acquired":false,"shares":3753,"price":105,"value":394065.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person. Accordingly, the reporting person had no discretion with regards to the timing of the transaction."}],"balance_after":14950,"source":{"system":"sec-edgar","filing":"0001209191-19-058217","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919119058217/doc4.xml","form_type":"4"}},{"id":3359327,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":16816,"kind":"person","name":"Howton David T","position":1,"cik":"0001529297","reported_name":"Howton David T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2019-11-27T01:01:00.000Z","date":"2019-11-22","kind":"sale","acquired":false,"shares":18290,"price":105,"value":1920450.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person. Accordingly, the reporting person had no discretion with regards to the timing of the transaction."}],"balance_after":18703,"source":{"system":"sec-edgar","filing":"0001209191-19-058217","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919119058217/doc4.xml","form_type":"4"}},{"id":3359326,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":16816,"kind":"person","name":"Howton David T","position":1,"cik":"0001529297","reported_name":"Howton David T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2019-11-27T01:01:00.000Z","date":"2019-11-22","kind":"exercise","acquired":true,"shares":8580,"price":13.9,"value":119262.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person. Accordingly, the reporting person had no discretion with regards to the timing of the transaction."}],"balance_after":36993,"source":{"system":"sec-edgar","filing":"0001209191-19-058217","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919119058217/doc4.xml","form_type":"4"}},{"id":3359325,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":16816,"kind":"person","name":"Howton David T","position":1,"cik":"0001529297","reported_name":"Howton David T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2019-11-27T01:01:00.000Z","date":"2019-11-22","kind":"exercise","acquired":true,"shares":4025,"price":13.71,"value":55182.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person. Accordingly, the reporting person had no discretion with regards to the timing of the transaction."}],"balance_after":28413,"source":{"system":"sec-edgar","filing":"0001209191-19-058217","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919119058217/doc4.xml","form_type":"4"}},{"id":3359324,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":16816,"kind":"person","name":"Howton David T","position":1,"cik":"0001529297","reported_name":"Howton David T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2019-11-27T01:01:00.000Z","date":"2019-11-22","kind":"exercise","acquired":true,"shares":5685,"price":13.71,"value":77941.35,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person. Accordingly, the reporting person had no discretion with regards to the timing of the transaction."}],"balance_after":24388,"source":{"system":"sec-edgar","filing":"0001209191-19-058217","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919119058217/doc4.xml","form_type":"4"}},{"id":3574429,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":16816,"kind":"person","name":"Howton David T","position":1,"cik":"0001529297","reported_name":"Howton David T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2019-03-30T00:00:28.000Z","date":"2019-03-28","kind":"tax_withholding","acquired":false,"shares":2362,"price":118.68,"value":280322.16,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Shares were withheld by the Company to satisfy tax withholding obligations related to a vesting of performance-based restricted stock units."}],"balance_after":18703,"source":{"system":"sec-edgar","filing":"0001209191-19-021876","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919119021876/doc4.xml","form_type":"4"}},{"id":3574428,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":16816,"kind":"person","name":"Howton David T","position":1,"cik":"0001529297","reported_name":"Howton David T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2019-03-30T00:00:28.000Z","date":"2019-03-28","kind":"grant","acquired":true,"shares":5319,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The transaction reflects the vesting of previously granted performance-based restricted stock units."}],"balance_after":21065,"source":{"system":"sec-edgar","filing":"0001209191-19-021876","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919119021876/doc4.xml","form_type":"4"}},{"id":3620939,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":16816,"kind":"person","name":"Howton David T","position":1,"cik":"0001529297","reported_name":"Howton David T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Stock option (right to buy)","published_at":"2019-03-05T01:07:53.000Z","date":"2019-03-04","kind":"grant","acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the option granted vests and is exercisable on the first anniversary of the date of grant and 1/48th of the total granted option will vest and become exercisable on each monthly anniversary thereafter, such that the option will be fully vested and exercisable on the fourth anniversary of the date of grant."}],"balance_after":45000,"derivative":{"exercise_price":145.48,"expiration_date":"2029-03-04","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001209191-19-016040","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919119016040/doc4.xml","form_type":"4"}},{"id":3620938,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":16816,"kind":"person","name":"Howton David T","position":1,"cik":"0001529297","reported_name":"Howton David T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2019-03-05T01:07:53.000Z","date":"2019-02-28","kind":"disposition_to_issuer","acquired":false,"shares":3825,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Forfeiture of 3,825 shares of restricted stock due to performance goal not met."}],"balance_after":15746,"source":{"system":"sec-edgar","filing":"0001209191-19-016040","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919119016040/doc4.xml","form_type":"4"}},{"id":3680388,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":16816,"kind":"person","name":"Howton David T","position":1,"cik":"0001529297","reported_name":"Howton David T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Stock Option (right to buy)","published_at":"2019-02-02T01:25:27.000Z","date":"2019-02-01","kind":"exercise","acquired":false,"shares":16827,"price":23.85,"value":401323.95,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 Plan. Accordingly, the reporting person had no discretion with regards to the timing of the transaction."}],"balance_after":116405,"derivative":{"exercise_price":23.85,"exercise_date":"2013-11-05","expiration_date":"2022-11-05","underlying":"Common Stock","underlying_shares":16827},"source":{"system":"sec-edgar","filing":"0001209191-19-006630","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919119006630/doc4.xml","form_type":"4"}},{"id":3680387,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":16816,"kind":"person","name":"Howton David T","position":1,"cik":"0001529297","reported_name":"Howton David T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Stock Option (right to buy)","published_at":"2019-02-02T01:25:27.000Z","date":"2019-02-01","kind":"exercise","acquired":false,"shares":1548,"price":13.71,"value":21223.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 Plan. Accordingly, the reporting person had no discretion with regards to the timing of the transaction."}],"balance_after":5883,"derivative":{"exercise_price":13.71,"exercise_date":"2016-09-19","expiration_date":"2025-09-19","underlying":"Common Stock","underlying_shares":1548},"source":{"system":"sec-edgar","filing":"0001209191-19-006630","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919119006630/doc4.xml","form_type":"4"}},{"id":3680386,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":16816,"kind":"person","name":"Howton David T","position":1,"cik":"0001529297","reported_name":"Howton David T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Stock Option (right to buy)","published_at":"2019-02-02T01:25:27.000Z","date":"2019-02-01","kind":"exercise","acquired":false,"shares":3125,"price":13.71,"value":42843.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 Plan. Accordingly, the reporting person had no discretion with regards to the timing of the transaction."}],"balance_after":6965,"derivative":{"exercise_price":13.71,"exercise_date":"2017-02-28","expiration_date":"2026-02-28","underlying":"Common Stock","underlying_shares":3125},"source":{"system":"sec-edgar","filing":"0001209191-19-006630","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919119006630/doc4.xml","form_type":"4"}},{"id":3680385,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":16816,"kind":"person","name":"Howton David T","position":1,"cik":"0001529297","reported_name":"Howton David T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Common Stock","published_at":"2019-02-02T01:25:27.000Z","date":"2019-02-01","kind":"sale","acquired":false,"shares":30000,"price":140,"value":4200000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 Plan. Accordingly, the reporting person had no discretion with regards to the timing of the transaction."}],"balance_after":19571,"source":{"system":"sec-edgar","filing":"0001209191-19-006630","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919119006630/doc4.xml","form_type":"4"}},{"id":3680384,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":16816,"kind":"person","name":"Howton David T","position":1,"cik":"0001529297","reported_name":"Howton David T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Common Stock","published_at":"2019-02-02T01:25:27.000Z","date":"2019-02-01","kind":"exercise","acquired":true,"shares":16827,"price":23.85,"value":401323.95,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 Plan. Accordingly, the reporting person had no discretion with regards to the timing of the transaction."}],"balance_after":49571,"source":{"system":"sec-edgar","filing":"0001209191-19-006630","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919119006630/doc4.xml","form_type":"4"}},{"id":3680383,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":16816,"kind":"person","name":"Howton David T","position":1,"cik":"0001529297","reported_name":"Howton David T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Common Stock","published_at":"2019-02-02T01:25:27.000Z","date":"2019-02-01","kind":"exercise","acquired":true,"shares":1548,"price":13.71,"value":21223.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 Plan. Accordingly, the reporting person had no discretion with regards to the timing of the transaction."}],"balance_after":32744,"source":{"system":"sec-edgar","filing":"0001209191-19-006630","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919119006630/doc4.xml","form_type":"4"}},{"id":3680382,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":16816,"kind":"person","name":"Howton David T","position":1,"cik":"0001529297","reported_name":"Howton David T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Common Stock","published_at":"2019-02-02T01:25:27.000Z","date":"2019-02-01","kind":"exercise","acquired":true,"shares":3125,"price":13.71,"value":42843.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 Plan. Accordingly, the reporting person had no discretion with regards to the timing of the transaction."}],"balance_after":31196,"source":{"system":"sec-edgar","filing":"0001209191-19-006630","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919119006630/doc4.xml","form_type":"4"}},{"id":3850111,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":16816,"kind":"person","name":"Howton David T","position":1,"cik":"0001529297","reported_name":"Howton David T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Common Stock","published_at":"2018-08-08T22:14:58.000Z","date":"2018-08-08","kind":"tax_withholding","acquired":false,"shares":6800,"price":121.02,"value":822936.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares were withheld by the Company to satisfy tax withholding obligations related to a vesting of performance-based restricted stock award granted on September 19, 2016."}],"balance_after":28071,"source":{"system":"sec-edgar","filing":"0001209191-18-045905","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919118045905/doc4.xml","form_type":"4"}},{"id":3866751,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":16816,"kind":"person","name":"Howton David T","position":1,"cik":"0001529297","reported_name":"Howton David T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Stock option (right to buy)","published_at":"2018-07-17T22:01:56.000Z","date":"2018-07-16","kind":"exercise","acquired":false,"shares":37848,"price":13.9,"value":526087.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on May 15, 2018. Accordingly, the reporting person had no discretion with regards to the timing of the transaction."}],"balance_after":27159,"derivative":{"exercise_price":13.9,"exercise_date":"2016-02-27","expiration_date":"2025-02-27","underlying":"Common Stock","underlying_shares":37848},"source":{"system":"sec-edgar","filing":"0001209191-18-042890","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919118042890/doc4.xml","form_type":"4"}},{"id":3866750,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":16816,"kind":"person","name":"Howton David T","position":1,"cik":"0001529297","reported_name":"Howton David T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Stock option (right to buy)","published_at":"2018-07-17T22:01:56.000Z","date":"2018-07-16","kind":"exercise","acquired":false,"shares":9056,"price":13.71,"value":124157.76,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on May 15, 2018. Accordingly, the reporting person had no discretion with regards to the timing of the transaction."}],"balance_after":10090,"derivative":{"exercise_price":13.71,"exercise_date":"2017-02-28","expiration_date":"2026-02-28","underlying":"Common Stock","underlying_shares":9056},"source":{"system":"sec-edgar","filing":"0001209191-18-042890","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919118042890/doc4.xml","form_type":"4"}},{"id":3866749,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":16816,"kind":"person","name":"Howton David T","position":1,"cik":"0001529297","reported_name":"Howton David T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Stock option (right to buy)","published_at":"2018-07-17T22:01:56.000Z","date":"2018-07-16","kind":"exercise","acquired":false,"shares":3096,"price":13.71,"value":42446.16,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on May 15, 2018. Accordingly, the reporting person had no discretion with regards to the timing of the transaction."}],"balance_after":7431,"derivative":{"exercise_price":13.71,"exercise_date":"2017-02-28","expiration_date":"2026-02-28","underlying":"Common Stock","underlying_shares":3096},"source":{"system":"sec-edgar","filing":"0001209191-18-042890","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919118042890/doc4.xml","form_type":"4"}},{"id":3866748,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":16816,"kind":"person","name":"Howton David T","position":1,"cik":"0001529297","reported_name":"Howton David T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Common Stock","published_at":"2018-07-17T22:01:56.000Z","date":"2018-07-16","kind":"sale","acquired":false,"shares":37848,"price":136.46,"value":5164738.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on May 15, 2018. Accordingly, the reporting person had no discretion with regards to the timing of the transaction."}],"balance_after":34871,"source":{"system":"sec-edgar","filing":"0001209191-18-042890","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919118042890/doc4.xml","form_type":"4"}},{"id":3866747,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":16816,"kind":"person","name":"Howton David T","position":1,"cik":"0001529297","reported_name":"Howton David T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Common Stock","published_at":"2018-07-17T22:01:56.000Z","date":"2018-07-16","kind":"exercise","acquired":true,"shares":37848,"price":13.9,"value":526087.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on May 15, 2018. Accordingly, the reporting person had no discretion with regards to the timing of the transaction."}],"balance_after":72719,"source":{"system":"sec-edgar","filing":"0001209191-18-042890","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919118042890/doc4.xml","form_type":"4"}},{"id":3866746,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":16816,"kind":"person","name":"Howton David T","position":1,"cik":"0001529297","reported_name":"Howton David T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Common Stock","published_at":"2018-07-17T22:01:56.000Z","date":"2018-07-16","kind":"sale","acquired":false,"shares":9056,"price":136.46,"value":1235781.76,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on May 15, 2018. Accordingly, the reporting person had no discretion with regards to the timing of the transaction."}],"balance_after":34871,"source":{"system":"sec-edgar","filing":"0001209191-18-042890","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919118042890/doc4.xml","form_type":"4"}},{"id":3866745,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":16816,"kind":"person","name":"Howton David T","position":1,"cik":"0001529297","reported_name":"Howton David T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Common Stock","published_at":"2018-07-17T22:01:56.000Z","date":"2018-07-16","kind":"exercise","acquired":true,"shares":9056,"price":13.71,"value":124157.76,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on May 15, 2018. Accordingly, the reporting person had no discretion with regards to the timing of the transaction."}],"balance_after":43927,"source":{"system":"sec-edgar","filing":"0001209191-18-042890","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919118042890/doc4.xml","form_type":"4"}},{"id":3866744,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":16816,"kind":"person","name":"Howton David T","position":1,"cik":"0001529297","reported_name":"Howton David T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Common Stock","published_at":"2018-07-17T22:01:56.000Z","date":"2018-07-16","kind":"sale","acquired":false,"shares":3096,"price":136.46,"value":422480.16,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on May 15, 2018. Accordingly, the reporting person had no discretion with regards to the timing of the transaction."}],"balance_after":34871,"source":{"system":"sec-edgar","filing":"0001209191-18-042890","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919118042890/doc4.xml","form_type":"4"}},{"id":3866743,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":16816,"kind":"person","name":"Howton David T","position":1,"cik":"0001529297","reported_name":"Howton David T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Common Stock","published_at":"2018-07-17T22:01:56.000Z","date":"2018-07-16","kind":"exercise","acquired":true,"shares":3096,"price":13.71,"value":42446.16,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on May 15, 2018. Accordingly, the reporting person had no discretion with regards to the timing of the transaction."}],"balance_after":37967,"source":{"system":"sec-edgar","filing":"0001209191-18-042890","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919118042890/doc4.xml","form_type":"4"}},{"id":3919469,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":16816,"kind":"person","name":"Howton David T","position":1,"cik":"0001529297","reported_name":"Howton David T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Restricted Stock Units","published_at":"2018-05-24T22:05:02.000Z","date":"2018-05-22","kind":"exercise","acquired":false,"shares":5319,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On March 10, 2017, the reporting person was granted restricted stock units that vest based on the Company's satisfaction of certain performance criteria. The first performance criterion was met on August 3, 2017, resulting in vesting of 50% of such restricted stock units, and the second performance criterion was met on May 22, 2018, resulting in vesting of additional 25% of such restricted stock units."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On March 10, 2017, the reporting person was granted restricted stock units that vest based on the Company's satisfaction of certain performance criteria. The first performance criterion was met on August 3, 2017, resulting in vesting of 50% of such restricted stock units, and the second performance criterion was met on May 22, 2018, resulting in vesting of additional 25% of such restricted stock units."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":5319},"source":{"system":"sec-edgar","filing":"0001209191-18-033109","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919118033109/doc4.xml","form_type":"4"}},{"id":3919468,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":16816,"kind":"person","name":"Howton David T","position":1,"cik":"0001529297","reported_name":"Howton David T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Common Stock","published_at":"2018-05-24T22:05:02.000Z","date":"2018-05-22","kind":"tax_withholding","acquired":false,"shares":1566,"price":89.22,"value":139718.52,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Shares were withheld by the Company to satisfy tax withholding obligations related to a vesting of restricted stock units granted on March 10, 2017."}],"balance_after":34871,"source":{"system":"sec-edgar","filing":"0001209191-18-033109","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919118033109/doc4.xml","form_type":"4"}},{"id":3919467,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":16816,"kind":"person","name":"Howton David T","position":1,"cik":"0001529297","reported_name":"Howton David T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Common Stock","published_at":"2018-05-24T22:05:02.000Z","date":"2018-05-22","kind":"exercise","acquired":true,"shares":5319,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":36437,"source":{"system":"sec-edgar","filing":"0001209191-18-033109","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919118033109/doc4.xml","form_type":"4"}},{"id":3993694,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":16816,"kind":"person","name":"Howton David T","position":1,"cik":"0001529297","reported_name":"Howton David T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Stock option (right to buy)","published_at":"2018-03-16T22:12:15.000Z","date":"2018-03-15","kind":"exercise","acquired":false,"shares":2074,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":13018,"derivative":{"exercise_price":23.85,"exercise_date":"2013-11-05","expiration_date":"2022-11-05","underlying":"Common Stock","underlying_shares":2074},"source":{"system":"sec-edgar","filing":"0001209191-18-020353","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919118020353/doc4.xml","form_type":"4"}},{"id":3993693,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":16816,"kind":"person","name":"Howton David T","position":1,"cik":"0001529297","reported_name":"Howton David T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Stock option (right to buy)","published_at":"2018-03-16T22:12:15.000Z","date":"2018-03-15","kind":"exercise","acquired":false,"shares":403,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":5590,"derivative":{"exercise_price":13.9,"exercise_date":"2016-02-27","expiration_date":"2025-02-27","underlying":"Common Stock","underlying_shares":403},"source":{"system":"sec-edgar","filing":"0001209191-18-020353","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919118020353/doc4.xml","form_type":"4"}},{"id":3993692,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":16816,"kind":"person","name":"Howton David T","position":1,"cik":"0001529297","reported_name":"Howton David T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Stock option (right to buy)","published_at":"2018-03-16T22:12:15.000Z","date":"2018-03-15","kind":"exercise","acquired":false,"shares":23,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":70,"derivative":{"exercise_price":13.71,"exercise_date":"2017-02-28","expiration_date":"2026-02-28","underlying":"Common Stock","underlying_shares":23},"source":{"system":"sec-edgar","filing":"0001209191-18-020353","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919118020353/doc4.xml","form_type":"4"}},{"id":3993691,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":16816,"kind":"person","name":"Howton David T","position":1,"cik":"0001529297","reported_name":"Howton David T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Common Stock","published_at":"2018-03-16T22:12:15.000Z","date":"2018-03-15","kind":"tax_withholding","acquired":false,"shares":609,"price":81.22,"value":49462.98,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person delivered already-owned shares of Common Stock in payment of the option exercise price. Such an \"option swap\" enables the exercise and holding of shares of Common Stock by the Reporting Person."}],"balance_after":31118,"source":{"system":"sec-edgar","filing":"0001209191-18-020353","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919118020353/doc4.xml","form_type":"4"}},{"id":3993690,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":16816,"kind":"person","name":"Howton David T","position":1,"cik":"0001529297","reported_name":"Howton David T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Common Stock","published_at":"2018-03-16T22:12:15.000Z","date":"2018-03-15","kind":"exercise","acquired":true,"shares":2074,"price":23.85,"value":49464.9,"ownership":{"direct":true},"balance_after":31727,"source":{"system":"sec-edgar","filing":"0001209191-18-020353","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919118020353/doc4.xml","form_type":"4"}},{"id":3993689,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":16816,"kind":"person","name":"Howton David T","position":1,"cik":"0001529297","reported_name":"Howton David T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Common Stock","published_at":"2018-03-16T22:12:15.000Z","date":"2018-03-15","kind":"tax_withholding","acquired":false,"shares":68,"price":81.22,"value":5522.96,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person delivered already-owned shares of Common Stock in payment of the option exercise price. Such an \"option swap\" enables the exercise and holding of shares of Common Stock by the Reporting Person."}],"balance_after":29653,"source":{"system":"sec-edgar","filing":"0001209191-18-020353","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919118020353/doc4.xml","form_type":"4"}},{"id":3993688,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":16816,"kind":"person","name":"Howton David T","position":1,"cik":"0001529297","reported_name":"Howton David T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Common Stock","published_at":"2018-03-16T22:12:15.000Z","date":"2018-03-15","kind":"exercise","acquired":true,"shares":403,"price":13.9,"value":5601.7,"ownership":{"direct":true},"balance_after":29721,"source":{"system":"sec-edgar","filing":"0001209191-18-020353","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919118020353/doc4.xml","form_type":"4"}},{"id":3993687,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":16816,"kind":"person","name":"Howton David T","position":1,"cik":"0001529297","reported_name":"Howton David T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Common Stock","published_at":"2018-03-16T22:12:15.000Z","date":"2018-03-15","kind":"tax_withholding","acquired":false,"shares":3,"price":81.22,"value":243.66,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person delivered already-owned shares of Common Stock in payment of the option exercise price. Such an \"option swap\" enables the exercise and holding of shares of Common Stock by the Reporting Person."}],"balance_after":29318,"source":{"system":"sec-edgar","filing":"0001209191-18-020353","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919118020353/doc4.xml","form_type":"4"}}],"next_cursor":"2018-03-16T22:12:15.000000Z,3993687"}